Sam Mulder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sam Mulder has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Abdallah Sherif Radwan Mohamed
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
3 shared publications - Clifton David Fuller
Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA
3 shared publications - Stephen Y. Lai
Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA
3 shared publications - Brigid A. McDonald
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
2 shared publications - Renjie He
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center
2 shared publications Sara Ahmed
The University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, TX, USA
2 shared publications
Latest Publications
- Open Access
Post head and neck cancer radiation therapy dynamic contrast enhanced magnetic resonance imaging association with high mandibular radiation dose
Background: Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) is a functional imaging modality that can quantify tissue permeability and blood flow. Due to vasculature changes resulting from radiation therapy (RT), DCE-MRI quantitative parameters should be significantly different in regions receiving a high radiation dose compared to regions receiving a low radiation dose. This work sought to determine if a significant difference exists in post head and neck cancer (HNC)-RT DCE-MRI quantitative parameters K trans and v e between regions of the mandible receiving a high radiation dose and regions of the mandible receiving a low radiation dose. Methods: DCE-MRI was acquired from HNC subjects post-RT. The DCE-MRI quantitative parameters K trans and v e were obtained through Tofts model fitting. Four mandible sections (left ramus, left body, right ramus, and right body) were delineated on subject mandible contours. Two Kruskal-Wallis tests comparing the mean K trans and v e in low dose (≤ 60 Gy) areas of the four mandible regions were computed. Next, two Wilcoxon signed-rank tests were used to determine if the means of K trans and v e between high dose (> 60 Gy) and low dose (≤ 60 Gy) mandible regions were significantly different. To account for multiple statistical tests, a Bonferroni corrected significance level for all statistical tests was used . Results: 48 HNC subjects were included in the analysis. The Kruskal-Wallis tests showed no inherent significant difference in K trans means between mandible regions and no inherent significant difference in v e means between mandible regions . No significant difference was found between high and low dose K trans mandible means ( W =392, p =0.044). A significant difference was found between high and low dose v e mandible means ( W =214, p =0.00013). Conclusions: No inherent difference in DCE-MRI quantitative parameters was observed within subject mandibles, but a significant difference was observed between v e means of high and low radiation dose mandible regions. These results provide evidence of the utility of DCE-MRI to monitor mandible vasculature changes resulting from head and neck cancer radiation therapy. Monitoring post HNC-RT mandible vasculature changes is important to initiate earlier toxicity management and ultimately improve HNC survivor quality of life. Simple Summary: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can detect relative differences in anatomical blood perfusion and vessel permeability. Differences in vascularity should occur between mandible regions receiving a large radiation dose and regions receiving a low radiation dose during head and neck cancer radiation therapy. In this study, we determined if DCE-MRI can be used to detect vasculature differences between mandible regions irradiated with high and low amounts of radiation. The results indicate that one of the DCE-MRI parameters was significantly different between irradiated mandible regions receiving high and low radiation dose. This parameter may be used as an early marker for mandible radiation damage from head and neck radiation therapy.
Open AccessPost head and neck cancer radiation therapy dynamic contrast enhanced magnetic resonance imaging association with high mandibular radiation dose
Background: Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) is a functional imaging modality that can quantify tissue permeability and blood flow. Due to vasculature changes resulting from radiation therapy (RT), DCE-MRI quantitative parameters should be significantly different in regions receiving a high radiation dose compared to regions receiving a low radiation dose. This work sought to determine if a significant difference exists in post head and neck cancer (HNC)-RT DCE-MRI quantitative parameters K trans and v e between regions of the mandible receiving a high radiation dose and regions of the mandible receiving a low radiation dose. Methods: DCE-MRI was acquired from HNC subjects post-RT. The DCE-MRI quantitative parameters K trans and v e were obtained through Tofts model fitting. Four mandible sections (left ramus, left body, right ramus, and right body) were delineated on subject mandible contours. Two Kruskal-Wallis tests comparing the mean K trans and v e in low dose (≤ 60 Gy) areas of the four mandible regions were computed. Next, two Wilcoxon signed-rank tests were used to determine if the means of K trans and v e between high dose (> 60 Gy) and low dose (≤ 60 Gy) mandible regions were significantly different. To account for multiple statistical tests, a Bonferroni corrected significance level for all statistical tests was used . Results: 48 HNC subjects were included in the analysis. The Kruskal-Wallis tests showed no inherent significant difference in K trans means between mandible regions and no inherent significant difference in v e means between mandible regions . No significant difference was found between high and low dose K trans mandible means ( W =392, p =0.044). A significant difference was found between high and low dose v e mandible means ( W =214, p =0.00013). Conclusions: No inherent difference in DCE-MRI quantitative parameters was observed within subject mandibles, but a significant difference was observed between v e means of high and low radiation dose mandible regions. These results provide evidence of the utility of DCE-MRI to monitor mandible vasculature changes resulting from head and neck cancer radiation therapy. Monitoring post HNC-RT mandible vasculature changes is important to initiate earlier toxicity management and ultimately improve HNC survivor quality of life. Simple Summary: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can detect relative differences in anatomical blood perfusion and vessel permeability. Differences in vascularity should occur between mandible regions receiving a large radiation dose and regions receiving a low radiation dose during head and neck cancer radiation therapy. In this study, we determined if DCE-MRI can be used to detect vasculature differences between mandible regions irradiated with high and low amounts of radiation. The results indicate that one of the DCE-MRI parameters was significantly different between irradiated mandible regions receiving high and low radiation dose. This parameter may be used as an early marker for mandible radiation damage from head and neck radiation therapy.
- Open Access
In Vivo Test-retest Quantitative Characterization of Echo Planar Imaging Apparent Diffusion Coefficient Reproducibility for Head and Neck Cancers on a 1.5T MR-Linac Platform: Technical Validation using QIBA Metrology
Background and Purpose: To detect changes in apparent diffusion coefficient (ADC) values during radiation therapy for biological image-guided adaptive radiation therapy, the variability in ADC must be characterized. We evaluated the reproducibility of ADC values in head and neck cancers on a 1.5T MR-linac. Methods: 39 head and neck cancer patients (36 primary tumors, 55 lymph nodes) were imaged with echo-planar imaging diffusion-weighted MRI on a 1.5T MR-linac at two time points before the start of radiation therapy. Mean and median ADC values and volume were measured for each lesion. Absolute and percent reproducibility coefficients (RC) were calculated. Linear regression analyses and F-tests were performed to determine whether lesion volume or time between scans impacted reproducibility. Results: For primary tumors & lymph nodes: mean ADC, median ADC, and volume were 1.27 ± 0.33 mm 2 /s & 1.17 ± 0.34 mm 2 /s, 1.25 ± 0.35 & 1.16 ± 0.37 mm 2 /s, and 8.8 ± 12.3 cm 3 & 6.5 ± 7.2 cm 3 , respectively. RC values of mean ADC were 0.355 mm 2 /s & 0.355 mm 2 /s for tumors & nodes, and %RC values were 29.1% & 31.1%; values were very similar for median ADC. Reproducibility was not significantly correlated with either volume or scan interval, but a trend of poorer reproducibility in smaller volumes was observed. Conclusion: Considering previous reports that the optimal %ΔADC threshold for response prediction in head and neck cancers is around 15-30%, this sequence on the MR-linac has acceptable reproducibility for detecting larger ADC changes but may still miss some clinically significant changes.
Open AccessIn Vivo Test-retest Quantitative Characterization of Echo Planar Imaging Apparent Diffusion Coefficient Reproducibility for Head and Neck Cancers on a 1.5T MR-Linac Platform: Technical Validation using QIBA Metrology
Background and Purpose: To detect changes in apparent diffusion coefficient (ADC) values during radiation therapy for biological image-guided adaptive radiation therapy, the variability in ADC must be characterized. We evaluated the reproducibility of ADC values in head and neck cancers on a 1.5T MR-linac. Methods: 39 head and neck cancer patients (36 primary tumors, 55 lymph nodes) were imaged with echo-planar imaging diffusion-weighted MRI on a 1.5T MR-linac at two time points before the start of radiation therapy. Mean and median ADC values and volume were measured for each lesion. Absolute and percent reproducibility coefficients (RC) were calculated. Linear regression analyses and F-tests were performed to determine whether lesion volume or time between scans impacted reproducibility. Results: For primary tumors & lymph nodes: mean ADC, median ADC, and volume were 1.27 ± 0.33 mm 2 /s & 1.17 ± 0.34 mm 2 /s, 1.25 ± 0.35 & 1.16 ± 0.37 mm 2 /s, and 8.8 ± 12.3 cm 3 & 6.5 ± 7.2 cm 3 , respectively. RC values of mean ADC were 0.355 mm 2 /s & 0.355 mm 2 /s for tumors & nodes, and %RC values were 29.1% & 31.1%; values were very similar for median ADC. Reproducibility was not significantly correlated with either volume or scan interval, but a trend of poorer reproducibility in smaller volumes was observed. Conclusion: Considering previous reports that the optimal %ΔADC threshold for response prediction in head and neck cancers is around 15-30%, this sequence on the MR-linac has acceptable reproducibility for detecting larger ADC changes but may still miss some clinically significant changes.
- Open Access
Improved Xerostomia Prediction in Head and Neck Cancer Patients with Dixon Magnetic Resonance Imaging of Glandular Adiposity: Validation of Semi-Quantitative Parotid T1 Signal Intensity Metrics for Biomarker Pre-Qualification
Purpose: Parotid whole-gland magnetic resonance (MR) T1 intensity, thresholded at the 90th percentile (T1 P90), has been previously reported to be a candidate MR imaging biomarker (MR-IBM) for improved prediction of xerostomia development after radiotherapy. Although P90 was previously derived from the parotid glands of T1-weighted MRI, in this study, we aim to validate P90 in an external cohort using fat only images reconstructed from a T1 Dixon MRI sequence, as well as determining alternative T1 intensity thresholds for potential qualification as predictive FDA BEST biomarkers of xerostomia development 6 months after radiotherapy (Xero 6m ). Methods: MR-IBMs derived from T1 Dixon intensity-normalized scans from 76 head and neck cancer (HNC) patients were extracted from pre-treatment MR images. Scans were normalized to fat tissue, and imaging characteristics were quantified. A reference model and MR-IBM models were created using multivariable logistic regression to predict Xero 6m . External validation was performed using the model coefficients described in a previous study. The area under the curve (AUC) of the resulting models were compared. Stepwise forward feature selection was performed to discover additional MR-IBMs for improved predictions of xerostomia. Results: The external validation of a previous model coefficients against our cohort showed decreased performance of the P90 MR-IBM model (AUC of 0.73 (CI 0.61-0.85)). The reference model exhibited improved performance when P90 was incorporated (AUC of 0.78 (CI 0.67-0.89)). Feature selection demonstrated the P10 MR-IBM provided performance improvements (AUC of 0.79 (CI: 0.69-0.90)). Conclusion: Our findings validated P90 as predictive biomarker for radiation-induced xerostomia and showed MR-IBMs derived from Dixon sequences can improve Xero 6m prediction when compared to the reference model. Formal biomarker qualification should be considered for T1 sequences/relaxometry via formalized approaches.
Open AccessImproved Xerostomia Prediction in Head and Neck Cancer Patients with Dixon Magnetic Resonance Imaging of Glandular Adiposity: Validation of Semi-Quantitative Parotid T1 Signal Intensity Metrics for Biomarker Pre-Qualification
Purpose: Parotid whole-gland magnetic resonance (MR) T1 intensity, thresholded at the 90th percentile (T1 P90), has been previously reported to be a candidate MR imaging biomarker (MR-IBM) for improved prediction of xerostomia development after radiotherapy. Although P90 was previously derived from the parotid glands of T1-weighted MRI, in this study, we aim to validate P90 in an external cohort using fat only images reconstructed from a T1 Dixon MRI sequence, as well as determining alternative T1 intensity thresholds for potential qualification as predictive FDA BEST biomarkers of xerostomia development 6 months after radiotherapy (Xero 6m ). Methods: MR-IBMs derived from T1 Dixon intensity-normalized scans from 76 head and neck cancer (HNC) patients were extracted from pre-treatment MR images. Scans were normalized to fat tissue, and imaging characteristics were quantified. A reference model and MR-IBM models were created using multivariable logistic regression to predict Xero 6m . External validation was performed using the model coefficients described in a previous study. The area under the curve (AUC) of the resulting models were compared. Stepwise forward feature selection was performed to discover additional MR-IBMs for improved predictions of xerostomia. Results: The external validation of a previous model coefficients against our cohort showed decreased performance of the P90 MR-IBM model (AUC of 0.73 (CI 0.61-0.85)). The reference model exhibited improved performance when P90 was incorporated (AUC of 0.78 (CI 0.67-0.89)). Feature selection demonstrated the P10 MR-IBM provided performance improvements (AUC of 0.79 (CI: 0.69-0.90)). Conclusion: Our findings validated P90 as predictive biomarker for radiation-induced xerostomia and showed MR-IBMs derived from Dixon sequences can improve Xero 6m prediction when compared to the reference model. Formal biomarker qualification should be considered for T1 sequences/relaxometry via formalized approaches.